tradingkey.logo
搜索

Arbutus Biopharma Corp

ABUS
添加自选
4.555USD
+0.125+2.82%
收盘 06/18, 16:00美东报价延迟15分钟
897.10M总市值
5.49市盈率 TTM

股东统计

更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Roivant Sciences Ltd.
19.73%
Morgan Stanley Investment Management Inc. (US)
13.01%
Whitefort Capital Management, LP
8.02%
Two Seas Capital LP
6.39%
BlackRock Institutional Trust Company, N.A.
5.88%
其他
46.98%
持股股东
持股股东
占比
Roivant Sciences Ltd.
19.73%
Morgan Stanley Investment Management Inc. (US)
13.01%
Whitefort Capital Management, LP
8.02%
Two Seas Capital LP
6.39%
BlackRock Institutional Trust Company, N.A.
5.88%
其他
46.98%
股东类型
持股股东
占比
Hedge Fund
24.34%
Investment Advisor/Hedge Fund
22.12%
Corporation
19.73%
Investment Advisor
16.48%
Research Firm
3.19%
Individual Investor
0.82%
Bank and Trust
0.33%
Pension Fund
0.20%
Insurance Company
0.02%
其他
12.77%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
317
128.81M
65.56%
+6.75M
2025Q4
303
120.46M
63.27%
+16.91K
2025Q3
308
120.41M
63.81%
+205.66K
2025Q2
303
120.18M
60.87%
+6.31M
2025Q1
305
113.89M
56.48%
+5.73M
2024Q4
291
105.12M
56.03%
+2.81M
2024Q3
289
102.16M
54.67%
+4.63M
2024Q2
265
97.30M
48.54%
+13.53M
2024Q1
263
83.76M
49.95%
-6.24M
2023Q4
266
79.35M
51.53%
+6.48M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Roivant Sciences Ltd.
38.85M
19.87%
--
--
Feb 25, 2025
Morgan Stanley Investment Management Inc. (US)
25.62M
13.11%
+2.30M
+9.87%
Dec 31, 2025
Whitefort Capital Management, LP
13.34M
6.83%
--
--
Dec 31, 2025
Two Seas Capital LP
12.59M
6.44%
+1.60M
+14.54%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
11.57M
5.92%
+292.37K
+2.59%
Dec 31, 2025
State Street Investment Management (US)
5.91M
3.02%
+1.81M
+44.16%
Dec 31, 2025
Adar1 Capital Management LLC
5.42M
2.77%
+2.51M
+86.52%
Dec 31, 2025
Adage Capital Management, L.P.
4.34M
2.22%
-675.00K
-13.46%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.68M
1.88%
+11.14K
+0.30%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Virtus LifeSci Biotech Clinical Trials ETF
0.89%
Invesco NASDAQ Future Gen 200 ETF
0.69%
Hypatia Women CEO ETF
0.28%
iShares Micro-Cap ETF
0.14%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.11%
ProShares Ultra Nasdaq Biotechnology
0.09%
Invesco Nasdaq Biotechnology ETF
0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
0.07%
State Street SPDR S&P Biotech ETF
0.06%
iShares Biotechnology ETF
0.06%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
占比0.89%
Invesco NASDAQ Future Gen 200 ETF
占比0.69%
Hypatia Women CEO ETF
占比0.28%
iShares Micro-Cap ETF
占比0.14%
iShares MSCI USA Small-Cap Min Vol Factor ETF
占比0.11%
ProShares Ultra Nasdaq Biotechnology
占比0.09%
Invesco Nasdaq Biotechnology ETF
占比0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
占比0.07%
State Street SPDR S&P Biotech ETF
占比0.06%
iShares Biotechnology ETF
占比0.06%
KeyAI